Archive for the ‘Viruses’ Category

Tick Data – 76% Infected With One Organism, 20% Have Three or More Pathogens

https://www.tickcheck.com/statistics?

Each tick submitted for testing contributes to the research being conducted at TickCheck. By keeping records of all the results generated, we have been able to gain valuable insights into disease prevalence and co-infection rates. The comprehensive testing panel has been especially helpful in contributing to this research by ensuring all diseases and coinfections are accounted for when examining a tick.

Our current research shows:
  • 76% of ticks tested have at least one disease causing organism
  • 49% are co-infected with two or more organisms
  • 20% carry three or more
  • 9% of the ticks tested carry four or more

Infection Visualization by Tick Species

All Ticks Tested
76% Positive for Infection
Negative (24%)
_____________________________
  • 93% Positive for Infection
  • Negative (7%)
  • 63% Positive for Infection
  • Negative (37%)
  • 48% Positive for Infection
  • Negative (52%)

Coinfection Visualization

  • 2+ coinfection 49%
  • No coinfection 51%

Pathogenic Prevalence

The information below shows the positive/negative prevalence ratio of selected pathogens we test for. These pathogens were observed in ticks from the United States and Canada. Data set includes tests performed since TickCheck’s founding in 2014 and is updated in real time. (

Go to link at beginning to filter by state.  I’ve added the 3 listed for Wisconsin next to the entire sample size.  Please note the small sample sizes of WI ticks. 

Borrelia burgdorferi (deer tick) associated with Lyme disease

Sample size of 3,280 ticks.           70 Wisconsin ticks
  • 30% postive                                           33% positive
  • 70% negative                                         67% negative

Borrelia burgdorferi (western blacklegged tick) associated with Lyme disease

Sample size of 279 ticks.
  • 4% positive
  • 96% negative

Borrelia burgdorferi (lone star tick) associated with Lyme disease

Sample size of 899 ticks.
  • 8% positive
  • 92% negative

Borrelia burgdorferi (American dog tick) associated with Lyme disease

Sample size of 901 ticks.
  • 2% positive
  • 98% negative

Anaplasma phagocytophilum associated with anaplasmosis

Sample size of 2,146 ticks.           36 Wisconsin ticks
  • 8% positive                                           11% positive in Wisconsin
  • 92% negative                                        89% negative in Wisconsin

Babesia microti associated with babesiosis

Sample size of 1,894 ticks.           32 Wisconsin ticks
  • 4% positive                                            6% positive
  • 96% negative                                        94% negative

Bartonella spp. associated with bartonellosis

Sample size of 1,060 ticks.
  • 47% positive
  • 53% negative

Ehrlichia chaffeensis associated with ehrlichiosis

Sample size of 857 ticks.
  • 2% positive
  • 98% negative

Rickettsia spp. associated with Rocky Mountain spotted fever

Sample size of 944 ticks.
  • 23% postive
  • 77% negative

Francisella tularensis associated with tularemia

Sample size of 1,028 ticks.
  • 1% positive
  • 99% negative

Borrelia miyamotoi associated with B. miyamotoi

Sample size of 1,091 ticks.
  • 6% postive
  • 94% negative

Borrelia lonestari associated with STARI

Sample size of 831 ticks.
  • 19% postitive
  • 81% negative

Babesia spp. associated with babesiosis

Sample size of 564 ticks.
  • 5% positive
  • 95% negative

Mycoplasma spp. associated with Mycoplasma spp.

Sample size of 948 ticks.
  • 8% positive
  • 92% negative

Borrelia spp. associated with Borrelia spp.

Sample size of 612 ticks.
  • 17% postive
  • 83% negative

Powassan virus Lineage II associated with Deer tick virus

Sample size of 102 ticks.
  • 24% positive
  • 76% negative

Borrelia mayonii associated with Lyme disease

Sample size of 376 ticks.
  • 100% negative

Ehrlichia ewingii associated with ehrlichiosis

Sample size of 283 ticks.
  • 100% negative

Rickettsia amblyommii associated with Rocky Mountain spotted fever

Sample size of 177 ticks.
  • 46% positive
  • 54% negative

__________________

For more about Tickcheckhttps://www.tickcheck.com/about

You can request free tick identification by sending in a quality picture of your tick. Using real-time PCR (Polymerase Chain Reaction), Tickcheck can determine the presence of certain pathogens with an accuracy level of over 99.9%.  All information about how to send in your tick, costs of various tests, time for results, etc. is found here:  https://www.tickcheck.com/info/faq

Jonathan Weber is the founder and CEO of TickCheck and became acutely aware of the dangers of tick-borne diseases after his father caught Lyme during a family trip on the Appalachian Trail.

___________________

**Comment**

This information supports current research showing many patients are infected with numerous pathogens causing more severe illness & requiring far more than the CDC’s mono therapy of doxycycline:  https://madisonarealymesupportgroup.com/2018/10/30/study-shows-lyme-msids-patients-infected-with-many-pathogens-and-explains-why-we-are-so-sick/

It also supports previous work showing coinfections within ticks:  https://madisonarealymesupportgroup.com/2017/05/01/co-infection-of-ticks-the-rule-rather-than-the-exception/

What I want to know is WHY nothing’s being done about this?  Why are people STILL given 21 days of doxycycline when that particular med will not work on numerous pathogens?
Lastly, a word about statistics – this tick data should be used with caution & never to turn sick patients away due to a statistic. If you are the sorry sucker who gets bit by that ONE tick carrying a “statistically insignificant” pathogen, you still got bit and have to deal with it.  
Shame on doctors for turning sick people away due to statistics and maps.
There’s no such thing as an “insignificant” tick bite!

But, Patients are STILL being turned away:  https://madisonarealymesupportgroup.com/2019/04/22/its-just-crazy-why-is-lyme-disease-treatment-so-difficult-to-find-in-mississippi/

https://madisonarealymesupportgroup.com/2019/03/19/jacksonville-family-shares-daughters-9-month-diagnosis-of-rare-disease-which-isnt-rare-lyme/

https://madisonarealymesupportgroup.com/2018/05/31/no-lyme-in-the-south-guess-again/

https://madisonarealymesupportgroup.com/2017/10/24/no-lyme-in-oklahoma-yeah-right/

https://madisonarealymesupportgroup.com/2016/09/24/arkansas-kids-denied-lyme-treatment/  “They had the classic symptoms, they had the bulls eye rash, they had the joint pain, they had fevers and had flu like symptoms, yet we were denied treatment for at least two of them and I don’t understand how this is legal,” said Bowerman.

According to Dr. Naveen Patil, Director of the Infectious Disease Program, ADH,

“We don’t have Lyme Disease in Arkansas, we have the ticks that transmit Lyme Disease but we don’t have any recorded cases of Lyme Disease.” 

Bowerman also received a letter from the clinic stating doctors would no longer treat her children because she consistently questioned their medical advice and recommendations.

This is getting to be way beyond ludicrous.

 

Co-infections in Persons With Early Lyme Disease

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433014/#__ffn_sectitle

. 2019 Apr; 25(4): 748–752.
PMCID: PMC6433014
PMID: 30882316

Co-infections in Persons with Early Lyme Disease, New York, USA

Abstract

In certain regions of New York state, USA, Ixodes scapularis ticks can potentially transmit 4 pathogens in addition to Borrelia burgdorferi: Anaplasma phagocytophilum, Babesia microti, Borrelia miyamotoi, and the deer tick virus subtype of Powassan virus. In a prospective study, we systematically evaluated 52 adult patients with erythema migrans, the most common clinical manifestation of B. burgdorferi infection (Lyme disease), who had not received treatment for Lyme disease. We used serologic testing to evaluate these patients for evidence of co-infection with any of the 4 other tickborne pathogens. Evidence of co-infection was found for B. microti only; 4–6 patients were co-infected with Babesia microti. Nearly 90% of the patients evaluated had no evidence of co-infection. Our finding of B. microti co-infection documents the increasing clinical relevance of this emerging infection.

__________________

**Comment**

Sigh…..where to even begin

rashes-larger-blog-2

  • They used serologic testing. Research has proven this form of testing is abysmal: https://madisonarealymesupportgroup.com/2018/10/12/direct-diagnostic-tests-for-lyme-the-closest-thing-to-an-apology-you-are-ever-going-to-get/  Key quote: “These serologic tests cannot distinguish active infection, past infection, or reinfection.”In plain English, these tests don’t show squat. While this study in the link was for Lyme testing, I assure you, serologic testing for coinfections is just as abysmal. All of these coinfections are stealthy and persistent. They purposely don’t hang out in the blood & they’ve developed strategies to avoid the immune system as well as treatment.
  • The fact they only found 1 coinfection isn’t a shocker. Some of the sickest patients NEVER test positive because of dysfunctional immune systems. I’m not sure when they are ever going to think of using a provoking agent to stir the pathogens up, kill them, and then get the dead pieces and parts into the blood where this abysmal testing for antibodies can be picked up, but I’m not going to hold my breath. This study seriously makes me want to bang my head against the wall. They’ve learned nothing and continue to do the same exact things.
  • The only thing they got right was the, increasing clinical relevance of this emerging infection,” but I’ve got news for them: this is just the tip of the iceberg.
  • They need to get Dr. Breitshwerdt in on these studies and allow him to test the patients for Bartonella using the tests he’s developed.  They also need to use provoking agents and then test, or use direct testing, and to drop the EM rash criteria like a bad habit.

 

 

 

 

 

Eye Problems in Tick-borne Diseases Other Than Lyme

http://danielcameronmd.com/eye-problems-tick-borne-diseases-lyme/

EYE PROBLEMS IN TICK-BORNE DISEASES OTHER THAN LYME

“Why should an ophthalmologist have a good understanding of Lyme diagnosis and treatment?” asks Sathiamoorthi [1], from the Mayo Clinic, in an article published in the Current Opinion in Ophthalmology. “Vision-threatening ophthalmic manifestations are relatively common in Lyme disease (LD) and Rocky Mountain spotted fever.”

by Daniel J. Cameron, MD MPH

“Knowledge of systemic and ophthalmic manifestations combined with an understanding of the epidemiology of disease vectors is crucial for the diagnosis of tick-borne diseases,” she explains.

While manifestations may be present with LD and Rocky Mountain spotted fever, ocular involvement is rare in other tick-borne diseases such as babesiosis, tick-borne relapsing fever, Powassan encephalitis, ehrlichiosis, anaplasmosis, and Colorado tick fever, Sathiamoorthi points out.

However, the true prevalence of ocular involvement due to tick-borne illnesses is unknown. Limitations with testing can make it difficult to identify patients. “It is crucial to know who is appropriate to test in order to avoid false positive results.” If an individual has been symptomatic for only a short period of time, they “may not have detectable serum IgM antibodies to the causative organism because it takes time for this immune response to develop.”

It can also be difficult to determine the cause of the ocular complaints if there is evidence of more than one tick-borne illness.

“One case report [2] describes a patient with optic neuritis and orbital myositis who had serologic evidence of HME [Human Monocytic Ehrlichioisis], Borrelia burgdorferi, and Babesia,” cites Sathiamoorthi.

There are more than one species of ticks associated with ocular findings, as well. According to Sathiamoorthi, those include Ornithodoros genus, Dermacentor variabilis Ambylomma americanum, Ixodes scapularis, and Dermacentor andersonii.

Sathiamoorthi advises doctors to “carefully generate a reasonable differential based on clues in the medical and social history regarding exposures and risks.”

“Patients who are most likely to have ophthalmic Lyme disease,” explains Sathiamoorthi, “are those with ocular manifestations commonly associated with Lyme disease (i.e. Bells palsy, cranial nerve palsies and keratitis); tick exposure in Lyme endemic regions; other signs/symptoms of late Lyme disease (i.e. inflammatory arthritis, carditis, acrodermatitis chronica atrophicans rash, encephalopathy and meningitis); and negative syphilis testing.”

Read more on eye problems in tick-borne diseases in “A growing list of eye problems in Lyme disease.”

References:

1. Sathiamoorthi S, Smith WM. The eye and tick-borne disease in the United States. Curr Opin Ophthalmol. 2016;27(6):530-537.
2. Pendse S, Bilyk JR, Lee MS. The ticking time bomb. Surv Ophthalmol. 2006;51(3):274-279.

 

African Tick Found on Untraveled U.K. Horse

https://www.ncbi.nlm.nih.gov/pubmed/30876825

2019 Apr;10(3):704-708. doi: 10.1016/j.ttbdis.2019.03.003. Epub 2019 Mar 9.

Hyalomma rufipes on an untraveled horse: Is this the first evidence of Hyalomma nymphs successfully moulting in the United Kingdom?

Abstract

During September 2018, a tick was submitted to Public Health England’s Tick Surveillance Scheme for identification. The tick was sent from a veterinarian who removed it from a horse in Dorset, England, with no history of overseas travel. The tick was identified as a male Hyalomma rufipes using morphological and molecular methods and then tested for a range of tick-borne pathogens including;

  • Alkhurma virus
  • Anaplasma
  • Babesia
  • Bhanja virus
  • Crimean-Congo Haemorrhagic fever virus
  • Rickettsia
  • Theileria

The tick tested positive for Rickettsia aeschlimannii, a spotted fever group rickettsia linked to a number of human cases in Africa and Europe.

This is the first time H. rufipes has been reported in the United Kingdom (UK), and the lack of travel by the horse (or any in-contact horses) suggests that this could also be the first evidence of successful moulting of a Hyalomma nymph in the UK. It is postulated that the tick was imported into the UK on a migratory bird as an engorged nymph which was able to complete its moult to the adult stage and find a host.

This highlights that passive tick surveillance remains an important method for the detection of unusual species that may present a threat to public health in the UK. Horses are important hosts of Hyalomma sp. adults in their native range, therefore, further surveillance studies should be conducted to check horses for ticks in the months following spring bird migration; when imported nymphs may have had time to drop off their avian host and moult to adults. The potential human and animal health risks of such events occurring more regularly are discussed.

_________________________

A ProMED-mail post

A tick capable of carrying a host of killer illnesses has been found in the UK for the very 1st time, health officials have revealed.

The _Hyalomma rufipes_ tick – a small blood-sucking arachnid – is usually confined to Africa, Asia and parts of southern Europe. But Public Health England [PHE] has now revealed one of the ticks, 10 times larger than others, was discovered in Dorset last year [2018]. The creature itself wasn’t found to be carrying the deadly Crimean-Congo Haemorrhagic fever virus (CCHF).

The disturbing find, which could ‘present a threat to public health in the UK’, has been documented in the journal Ticks and Tick-borne Diseases.

A vet at The Barn Equine Surgery in Wimborne removed the tick from a horse last September [2018]. They then sent it to PHE’s tick surveillance team. Writing in the journal, the PHE team said: ‘This is the first time _Hyalomma rufipes_ has been reported in the United Kingdom. ‘The lack of travel by the horse – or any in-contact horses – suggests that this could also be the 1st evidence of successful moulting of a _Hyalomma_ nymph in the UK.’

The team of researchers who found the tick was led by Kayleigh Hansford, of PHE’s medical entomology and zoonoses ecology group.

Writing in the journal, they said it is suspected the tick hitched a ride on a migratory bird before landing in the UK. Neither the infested horse, nor other horses in the stable had travelled anywhere and no further ticks were detected on any of the horses. It is thought the tick travelled on a swallow because they are known to nest in the stables of horses and migrate from Africa to the UK for summer.

The UK climate, known to be getting warmer, is thought to be a major limiting factor for the survival of _Hyalomma rufipes_. However, the unusually warm weather experienced during the summer of 2018 may have been a factor for helping it moult – become an adult.

Currently, the ticks are found in Greece, Northern China, Russia, Turkey, Iraq, Syria, Pakistan, Egypt, Yemen and Oman.

The World Health Organization last year [2018] named CCHF as one of 10 pathogens that pose the most ‘urgent’ threat to humanity.

Figures show the virus – most often spread through tick bites – kills around 40% of humans that it strikes. The horrific illness is said to manifest ‘abruptly’, with initial symptoms including fever, backache, headache, dizziness and sore eyes.

[Byline: Stephen Matthews]


Communicated by:
ProMED-mail Rapporteur Mary Marshall

[Not mentioned in detail in the above report, the PHE team, using morphological and molecular methods, then tested for a range of tick-borne pathogens including: Alkhurma virus, Anaplasma, Babesia, Bhanja virus, Crimean-Congo Haemorrhagic fever virus, Rickettsia and Theileria. The tick tested positive for _Rickettsia aeschlimannii_, a spotted fever group rickettsia linked to a number of human cases in Africa and Europe.

The critical question is if this is a single tick transported into Dorset, or represents one tick of a local breeding population. Transportation of a single tick by a migrating bird is a reasonable possibility. Immature (nymph) _Hyalomma_ usually feed on birds, rodents, and hares. Nymphs are often transported from one place to another by migrating birds. For example, a migrating bird carrying a CCH virus-infected _Hyalomma marginatum_ nymph can introduce the virus into new localities and infect humans and domestic livestock (Larry S.Roberts, 2009). Continued surveillance in the area where the single tick was found, as well as generally in the UK over the spring and summer months, would be prudent.

 

Could Dogs be the Source of a New Flu?

https://m.phys.org/news/2019-03-dogs-source-flu.html

Could dogs be the source of a new flu?

March 28, 2019 , Microbiology Society
dog

Credit: CC0 Public Domain

Results from a 10-year study suggest two strains of influenza that could mix and form a dangerous new strain of influenza spread by dogs.

Dr. Daesub Song, Associate Professor (Korea University, Republic of Korea) has called for closer monitoring of dogs and other as they could be a source of novel human influenza . He said,

“Until now, dogs were considered neglected hosts in the field of flu research. However, after the first report of interspecies transmission, surveillance of flu viruses from companion animals should be further strengthened.”

In the 2000s, several cases of viruses crossing the host barrier were recorded. Most notably, H3N2 bird flu crossed over to dogs and developed into Canine Influenza virus (CIV). Dr. Song’s research has found that this H3N2 CIV could combine with H1N1/2009 and form a new influenza virus, called CIVmv.

The emergence of new species of influenza such as this is concerning. Those infected will have not come into contact with a virus like this before, meaning they would not have immunity to the disease. If the virus could be carried and spread to humans from companion animals, it could have the potential to spread throughout the population extremely quickly.

H1N1/2009 is known for causing the 2009-2010 global ‘swine flu’ pandemic. When this strain of influenza combines with CIV in dogs, some of the viruses recombine to form CIVmv. Although CIVmv is very similar to CIV, researchers have calculated there is a much higher risk of the disease spreading to humans due to its high infection rates in ferrets.

Viruses bind to host cells and cause infection via sialic acid (SA) receptors, which differ between species. Ferrets have very similar SA receptors to humans. Because of this, ferrets are considered themost reliable experimental model for predicting and evaluating the risk of novel human influenza viruses.

During their studies of the new CIVmv strain, Dr. Song noted that infected dogs and ferrets displayed typical symptoms of respiratory disease, including congestion, breathing difficulties, coughing, runny eyes, sneezing, lethargy, and appetite loss. As well as these symptoms, Dr. Song reported the new strain spread between ferrets more quickly than other influenza viruses and replicated quickly.

Researchers are trying to develop a vaccine for the virus. However, due to the high level of mutations, vaccines are very difficult to develop.

Despite being named Canine Influenza Virus, it is not just dogs that can be infected by CIV. During the ten-year study, researchers found that cats were also susceptible to the virus. Dr. Song investigated an outbreak of CIV in an animal shelter, during which 100% of the cats were infected and 40% died.

The development of susceptibility in cats is worrying as it shows that CIV can spread amongst different animal species. Researchers have raised concerns as there is a potential for the to become endemic in companion animals. As both and are in frequent contact with humans, much more frequently than pigs or chickens, the potential risk for a new strain to develop and infect humans is even higher.

Since being first identified in South Korea, CIV has spread to China, Thailand and USA. A case of CIVmv infection was identified in a dog in 2012 following an epidemic of H1N1. Dr. Song used this strain in ferrets to determine whether it had the potential to spread from canines to humans. From there, a novel human influenza strain could emerge. Dr. Song said, “Pre-existing CIV may recombine or reassort with human viruses and give rise to novel viruses that could in turn lead to unique pandemics.”